|
1
|
Onuora S. Benralizumab noninferior to mepolizumab for EGPA. Nat Rev Rheumatol 2024; 20:253. [PMID: 38594482 DOI: 10.1038/s41584-024-01116-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/11/2024]
|
|
2
|
Onuora S. Eosinophils regulate bone remodelling. Nat Rev Rheumatol 2024:10.1038/s41584-024-01100-0. [PMID: 38454053 DOI: 10.1038/s41584-024-01100-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/09/2024]
|
|
3
|
Onuora S. GWAS data help unravel Dupuytren disease. Nat Rev Rheumatol 2024; 20:137. [PMID: 38332241 DOI: 10.1038/s41584-024-01091-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2024]
|
|
4
|
Onuora S. B cells guide rituximab use in AAV remission. Nat Rev Rheumatol 2024; 20:67. [PMID: 38212541 DOI: 10.1038/s41584-024-01078-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2024]
|
|
5
|
Onuora S. Multi-omics reveals distinct MPA subtypes. Nat Rev Rheumatol 2024; 20:3. [PMID: 38040801 DOI: 10.1038/s41584-023-01061-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2023]
|
|
6
|
Onuora S. Targeted NOD2 sequencing uncovers JIA misdiagnosis. Nat Rev Rheumatol 2024; 20:3. [PMID: 38030937 DOI: 10.1038/s41584-023-01060-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2023]
|
|
7
|
Onuora S. Collagen-binding antibody prevents arthritis. Nat Rev Rheumatol 2023; 19:759. [PMID: 37848551 DOI: 10.1038/s41584-023-01046-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2023]
|
|
8
|
Onuora S. L-arginine inhibits arthritis and bone loss by reprogramming osteoclast metabolism. Nat Rev Rheumatol 2023; 19:760. [PMID: 37919338 DOI: 10.1038/s41584-023-01055-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2023]
|
|
9
|
Onuora S. SLC26A2 deficiency, matrix stiffness and mechanotransduction linked in osteoporosis. Nat Rev Rheumatol 2023; 19:677. [PMID: 37789117 DOI: 10.1038/s41584-023-01041-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/05/2023]
|
|
10
|
Onuora S. Pre-exposure prophylaxis reduces risk of COVID-19. Nat Rev Rheumatol 2023; 19:677. [PMID: 37789116 DOI: 10.1038/s41584-023-01039-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/05/2023]
|
|
11
|
Onuora S. SGLT2 inhibitors protect podocytes in lupus nephritis. Nat Rev Rheumatol 2023; 19:605. [PMID: 37666997 DOI: 10.1038/s41584-023-01024-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/06/2023]
|
|
12
|
Onuora S. Interosseous tendon inflammation associated with arthritis risk. Nat Rev Rheumatol 2023; 19:538. [PMID: 37532783 DOI: 10.1038/s41584-023-01012-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/04/2023]
|
|
13
|
Onuora S. Aminoacyl-tRNA synthetases function as alarmins in RA. Nat Rev Rheumatol 2023; 19:538. [PMID: 37537377 DOI: 10.1038/s41584-023-01020-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/05/2023]
|
|
14
|
Onuora S. NETs implicated in periodontitis-associated bone loss. Nat Rev Rheumatol 2023; 19:463. [PMID: 37430108 DOI: 10.1038/s41584-023-01000-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/12/2023]
|
|
15
|
Onuora S. Low back pain is a growing concern. Nat Rev Rheumatol 2023:10.1038/s41584-023-00999-1. [PMID: 37430106 DOI: 10.1038/s41584-023-00999-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/12/2023]
|
|
16
|
Onuora S. Rheumatic diseases on the rise. Nat Rev Rheumatol 2023:10.1038/s41584-023-00990-w. [PMID: 37286759 DOI: 10.1038/s41584-023-00990-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
|
|
17
|
Onuora S. PJP prophylaxis with rituximab. Nat Rev Rheumatol 2023:10.1038/s41584-023-00982-w. [PMID: 37217611 DOI: 10.1038/s41584-023-00982-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
|
|
18
|
Onuora S. Which DMARD for ICI-associated arthritis? Nat Rev Rheumatol 2023:10.1038/s41584-023-00983-9. [PMID: 37217610 DOI: 10.1038/s41584-023-00983-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
|
|
19
|
Onuora S. Targeting KDM2/7 histone demethylases could protect against OA. Nat Rev Rheumatol 2023; 19:326. [PMID: 37165088 DOI: 10.1038/s41584-023-00978-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
|
20
|
Onuora S. Antibodies cross-reactive with DNase1L3 and dsDNA discovered. Nat Rev Rheumatol 2023; 19:325. [PMID: 37165087 DOI: 10.1038/s41584-023-00977-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|
|
21
|
Onuora S. Mitochondrial fumarate implicated in inflammation. Nat Rev Rheumatol 2023; 19:257. [PMID: 37024712 DOI: 10.1038/s41584-023-00963-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/08/2023]
|
|
22
|
Onuora S. Biologic choice matters in PsA prevention. Nat Rev Rheumatol 2023; 19:256. [PMID: 36964335 DOI: 10.1038/s41584-023-00955-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/26/2023]
|
|
23
|
Onuora S. PR3 triggers granuloma formation in GPA. Nat Rev Rheumatol 2023; 19:194. [PMID: 36878985 DOI: 10.1038/s41584-023-00943-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/08/2023]
|
|
24
|
Onuora S. Bimekizumab effective across the axSpA spectrum. Nat Rev Rheumatol 2023; 19:127. [PMID: 36755118 DOI: 10.1038/s41584-023-00927-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
|
|
25
|
Onuora S. No benefit from adding MTX to ustekinumab. Nat Rev Rheumatol 2023; 19:129. [PMID: 36717632 DOI: 10.1038/s41584-023-00912-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
|
26
|
Onuora S. VEXAS syndrome more common than originally thought? Nat Rev Rheumatol 2023; 19:193. [PMID: 36792664 DOI: 10.1038/s41584-023-00931-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
|
27
|
Onuora S. Fetuin-A peptide inhibits cartilage calcification. Nat Rev Rheumatol 2023; 19:63. [PMID: 36627395 DOI: 10.1038/s41584-023-00907-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
|
28
|
Onuora S. 'Hyalinization' for cartilage regeneration. Nat Rev Rheumatol 2023; 19:63. [PMID: 36550319 DOI: 10.1038/s41584-022-00898-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
|
29
|
Onuora S. Fibroblast A20 and its suppressor DREAM regulate fibrosis in SSc. Nat Rev Rheumatol 2023; 19:1. [PMID: 36477148 DOI: 10.1038/s41584-022-00886-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
|
30
|
|
|
31
|
Onuora S. Sulf2 mediates the effects of TNF in RASFs. Nat Rev Rheumatol 2022; 18:613. [PMID: 36167820 DOI: 10.1038/s41584-022-00853-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
32
|
Onuora S. Calprotectin tracks tocilizumab-treated RA. Nat Rev Rheumatol 2022; 18:612. [PMID: 36163436 DOI: 10.1038/s41584-022-00851-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
33
|
Onuora S. Immune cell profiles stratify AOSD endotypes. Nat Rev Rheumatol 2022; 18:612. [PMID: 36163437 DOI: 10.1038/s41584-022-00852-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
34
|
Onuora S. NETs implicated in COVID-19 in kids and adults. Nat Rev Rheumatol 2022; 18:552. [PMID: 35953558 PMCID: PMC9366817 DOI: 10.1038/s41584-022-00830-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
35
|
Onuora S. Cell-cell interactions shape RA and PsA pathogenesis. Nat Rev Rheumatol 2022; 18:431. [PMID: 35821339 DOI: 10.1038/s41584-022-00811-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
36
|
Onuora S. Machine learning reveals antibody signature. Nat Rev Rheumatol 2022; 18:431. [PMID: 35761071 DOI: 10.1038/s41584-022-00806-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
|
37
|
Onuora S. Low-dose glucocorticoids benefit seniors with RA. Nat Rev Rheumatol 2022; 18:431. [PMID: 35761072 DOI: 10.1038/s41584-022-00805-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
38
|
Onuora S. sCD13 role in arthritis mediated via bradykinin receptor. Nat Rev Rheumatol 2022; 18:306. [PMID: 35545682 DOI: 10.1038/s41584-022-00792-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
39
|
Onuora S. Freeing PDL1 alleviates autoimmunity. Nat Rev Rheumatol 2022; 18:185. [PMID: 35288667 DOI: 10.1038/s41584-022-00772-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
40
|
Onuora S. Neutrophils implicated in early enthesitis. Nat Rev Rheumatol 2022; 18:127. [DOI: 10.1038/s41584-022-00750-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
41
|
Onuora S. Guselkumab effective through 2 years in PsA trial. Nat Rev Rheumatol 2021; 18:4. [PMID: 34862490 DOI: 10.1038/s41584-021-00733-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
42
|
|
|
43
|
Onuora S. Knee OA progression risk with steroids or HA. Nat Rev Rheumatol 2021; 18:4. [PMID: 34862491 DOI: 10.1038/s41584-021-00731-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
44
|
Onuora S. Secukinumab might improve enthesitis in SpA. Nat Rev Rheumatol 2021; 18:4. [PMID: 34862492 DOI: 10.1038/s41584-021-00734-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
45
|
Onuora S. Anti-TNF dose can be reduced in PsA and axSpA. Nat Rev Rheumatol 2021; 17:707. [PMID: 34707222 DOI: 10.1038/s41584-021-00714-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
46
|
Onuora S. Treatment withdrawal is feasible in RA remission. Nat Rev Rheumatol 2021; 17:707. [PMID: 34707219 DOI: 10.1038/s41584-021-00717-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
47
|
Onuora S. Rituximab shows potential for treatment of PMR. Nat Rev Rheumatol 2021; 17:644. [PMID: 34584261 DOI: 10.1038/s41584-021-00702-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
48
|
Onuora S. Profiling comorbidities of inclusion body myositis. Nat Rev Rheumatol 2021; 17:644. [PMID: 34584263 DOI: 10.1038/s41584-021-00703-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
49
|
Onuora S. Antibodies induce fibromyalgia symptoms. Nat Rev Rheumatol 2021; 17:507. [PMID: 34354268 DOI: 10.1038/s41584-021-00679-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
50
|
Onuora S. Synthetic Wnt agonists rapidly rebuild bone in vivo. Nat Rev Rheumatol 2021; 17:442. [PMID: 34230643 DOI: 10.1038/s41584-021-00664-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|